|
How many volunteers were present at this meeting? : |
1150 |
|
Which countries were presented in congress? : |
United States, Germany, France, Portugal, United Kingdom, Morraco, Saudi Arabia, Brazil, Turkey, Argentina, Denmark, Canada, Australia, Iran |
|
were any organizations represented in the meeting? : |
Yes |
|
If yes, please write the names of the organization in the box : |
American College of Medical Genetics |
|
What were the response to your talking points? were specific questions or concerns raised? : |
Fair enough due to 2 posters which I presented:
1- Re the pattern of SLC4A1 gene mutation in Iran
2- Re the rate of breast cancer in Iran |
|
If you met with staff members, please list their full name & positions. : |
Dr. Mj Hajianpour, MD, PhD
Clinical Cytogenetics
mj@hajianpour.com |
|
Please make a note if there are any follow up actions we need to talk with the member of congress : |
First, it is crucial to avoid and warn on any single extension of the sanctions to academic and scientific based on OFAC agreement in the States.
Second, it seems to be necessary to reconsider the quality and quantity of financial aid (reimbursement) for participation of the faculty members in the International seminars/congresses due to the exchange rate inflation. Otherwise, it would be almost impossible and with a lot of hardship to attend such these seminars which are essential for academic activities. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Good but exhausting, too long and multiple connections! |
|
Meeting summary:(include: names of every one in attendance, outcomees and personal observatons of the metting, and please make a note if there are any follow up actions we need to take with the member of congress or their staff): : |
Annually in mid March, American College of Medical Genetics meeting occurs mostly in the convention center of a city in the north America. This year (2013) it was held in Phoenix, AZ, while most of the participants were from USA.
My 2 presentations did appeal to two scientific different groups: one from cancer institute of the Baylor College of Medicine (Texas) re the breast cancer stem cell; and the other by a colleague from university of Cincinnati (Ohio) regarding the mutational profile and panel of SLC4A1 in the patients involved in distal renal tubular acidosis (dRTA) and other nephrogenetic panels which are available in Iran resulting in an interest to establish a collaboration.
Most of the presentations focoused on the new molecular genetics techniques including WGA, NGS, and exome sequencing, and their applications in modern molecular medicine. |